ADELE BROUSSARD: Open Payments
NPI 1972118842 · RACELAND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 20 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $304 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 5 | $96 |
| Lilly USA, LLC | 3 | $52 |
| ABBVIE INC. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| RGH Enterprises LLC | 1 | $29 |
| Sequel Med Tech, LLC | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Novo Nordisk Inc | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: iLet Bionic Pancreas, MOUNJARO, JARDIANCE, QULIPTA, TWIIST, Korlym, SPRAVATO, Ozempic.
Industry payments across LA — which companies pay providers there.
